24 related articles for article (PubMed ID: 12556144)
1. The immunodominant Brugia malayi paramyosin as a marker of current infection with Wuchereria bancrofti adult worms.
Langy S; Plichart C; Luquiaud P; Williams SA; Nicolas L
Infect Immun; 1998 Jun; 66(6):2854-8. PubMed ID: 9596759
[TBL] [Abstract][Full Text] [Related]
2. Diethylcarbamazine activates TRP channels including TRP-2 in filaria, Brugia malayi.
Verma S; Kashyap SS; Robertson AP; Martin RJ
Commun Biol; 2020 Jul; 3(1):398. PubMed ID: 32724078
[TBL] [Abstract][Full Text] [Related]
3. Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models.
Marriott AE; Sjoberg H; Tyrer H; Gamble J; Murphy E; Archer J; Steven A; Taylor MJ; Turner JD
Sci Rep; 2018 Apr; 8(1):5910. PubMed ID: 29651095
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the recombinant antigens Wb14 and WbT for the capture antibody diagnosis of lymphatic filariasis.
Pastor AF; Rocha A; Cassemiro KM; Tenório M; Melo P; Grilis MR; Rhuama M; Rezende AM; Melo Neto OP; Marques E; Dhalia R
Mem Inst Oswaldo Cruz; 2018 Mar; 113(5):e170435. PubMed ID: 29590236
[TBL] [Abstract][Full Text] [Related]
5. Differential decline in filaria-specific IgG1, IgG4, and IgE antibodies in Brugia malayi-infected patients after diethylcarbamazine chemotherapy.
Atmadja AK; Atkinson R; Sartono E; Partono F; Yazdanbakhsh M; Maizels RM
J Infect Dis; 1995 Dec; 172(6):1567-72. PubMed ID: 7594718
[TBL] [Abstract][Full Text] [Related]
6. Immunomonitoring of filarial patients during DEC therapy in an endemic area: a seven-year follow-up.
Padigel UM; Reddy MV; Alikhan A; Harinath BC
J Trop Med Hyg; 1995 Feb; 98(1):52-6. PubMed ID: 7861480
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulator tuftsin augments antifilarial activity of diethylcarbamazine against experimental brugian filariasis.
Owais M; Misra-Bhattacharya S; Haq W; Gupta CM
J Drug Target; 2003 May; 11(4):247-51. PubMed ID: 14578113
[TBL] [Abstract][Full Text] [Related]
8. Effects of 5 rounds of mass drug administration with diethylcarbamazine and albendazole on filaria-specific IgG4 titers in urine: 6-year follow-up study in Sri Lanka.
Itoh M; Weerasooriya MV; Yahathugoda TC; Takagi H; Samarawickrema WA; Nagaoka F; Kimura E
Parasitol Int; 2011 Dec; 60(4):393-7. PubMed ID: 21723413
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: follow-up at 10 years after treatment.
Meyrowitsch DW; Simonsen PE; Magesa SM
Trans R Soc Trop Med Hyg; 2004 Nov; 98(11):627-34. PubMed ID: 15363642
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of treatment with diethylcarbamazine on anti-filarial IgG4: dosage, compliance, and differential patterns in adults and children.
Terhell AJ; Haarbrink M; van den Biggelaar A; Mangali A; Sartono E; Yazdanbakhsh M
Am J Trop Med Hyg; 2003 Jan; 68(1):33-9. PubMed ID: 12556144
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic filariasis and Brugia timori: prospects for elimination.
Fischer P; Supali T; Maizels RM
Trends Parasitol; 2004 Aug; 20(8):351-5. PubMed ID: 15246315
[TBL] [Abstract][Full Text] [Related]
12. Filarial infections.
Ottesen EA
Infect Dis Clin North Am; 1993 Sep; 7(3):619-33. PubMed ID: 8254163
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
